Hemorrhagic stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet the above diagnostic criteria for hemorrhagic stroke; (2) Age 18~75 years old, gender, occupation, ethnicity is not limited; (3) Patients and their families voluntarily participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients who have been suffered from LEDVT by color ultrasound examination before enrollment; (2) Those who have lower limb vascular diseases and lower limb skin defects, death, or fractures before admission, and who need surgery on the lower limbs recently; (3) Patients with poor compliance and refusal to cooperate; (4) Use of oral or subcutaneous anticoagulant drugs, such as rivaroxaban, warfarin, low molecular weight heparin, etc., during the study; ? (5) Treatment of local skin abnormalities at acupuncture points or allergies to electrodes and conductive adhesives, such as ulceration, gangreus, dermatitis, recent skin graft surgery, etc.; ? (6) Combined with other diseases that seriously affect the quality of life and/or seriously affect the quality of investigation, such as mental abnormalities and Alzheimer's disease, etc., those who cannot cooperate; (7) Patients who cannot tolerate transcutaneous acupoint electrical stimulation operations; (8) Those who are equipped with a pacemaker or implanted steel nails or plates that have an impact on the current; (9) Patients who have been hospitalized for less than 14 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether venous thrombosis of the lower extremities has occurred; | — |
Secondary
| Measure | Time frame |
|---|---|
| homocysteine;D-dimer;Prothrombin time;fibrinogen;INR;Platelet count; | — |
Countries
China
Contacts
The Second Affiliated Hospital of the University of South China